Monday, April 22, 2019 1:28:46 PM
Last 10-K
As of March 15, 2019, our common stock was held by 74 stockholders of record and we had 71,614,917 shares of common stock issued and outstanding. We believe that the number of beneficial owners is substantially greater than the number of record holders because a significant portion of our outstanding common stock is a hero or record in broker street names for the benefit of individual investors.
All Executive Officers and Directors as a Group (4 persons) 22,267,765 27.7%
Left for Stockholders = 49,347,152/70 = 707,959 shares
Avg 14,159 USD / stockholder investment.
But as they write themselves: "We believe that the number of beneficial owners is substantially greater than the number of record holders because a significant portion or our outstanding common stock is hero or record in broker street names for the benefit of individual investors."
The number of stockholders can be X10 which brings the Avg 1,415.9 USD / stockholder investment.
Which is very low for a potential share like this.
Recent NEWH News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 10:00:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:56:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 08:30:37 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM